<DOC>
	<DOCNO>NCT01755442</DOCNO>
	<brief_summary>This phase 1 , randomize , double-blind , placebo-controlled , 2-way crossover study evaluate effect AMG 151 24-hour ambulatory blood pressure glucose level subject type 2 diabetes mellitus stable regimen metformin alone , metformin dipeptidyl peptidase-4 inhibitor ( DPP4 ) , metformin thiazolidinedione ( TZD ) , metformin , DPP4 , TZD minimum 3 month prior randomization .</brief_summary>
	<brief_title>Investigate Effect AMG 151 24-hour Ambulatory Blood Pressure &amp; Glucose Levels Type 2 Diabetes Mellitus Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Inclusion Criteria Subjects type 2 diabetes mellitus On stable regimen metformin alone , metformin DPP4 , metformin TZD , metformin , DPP4 , TZD minimum 3 month prior randomization Body mass index &gt; 25 &lt; 45 kg/m2 Hemoglobin A1c level ≥ 7.0 % ≤ 11.0 % screen Fasting Cpeptide level ≥ 0.2 nmol/L screen Subject history hypertension must stable antihypertensive treatment ( ) ( type medication , dose , regimen ) least 6 week prior first dose investigational product Other criterion may apply Exclusion Criteria Subject type 1 diabetes mellitus history type 1 diabetes mellitus Subject 2 emergency room visit hospitalization due poor glucose control 6 month prior screen Poorly control hypertension define diastolic pressure ≥ 95 mmHg systolic ≥ 155 mmHg ( confirm repeat assessment ) screen Triglycerides ≥ 400 mg/dL ( 4.52 mmol/L ) screening Use know cytochrome P450 ( CYP ) inducer within 30 day 5 halflives ( whichever longer ) , prior receive first dose investigational product . Use known inhibitor CYP3A4/Pglycoprotein within 14 day 5 half life ( whichever longer ) prior receive first dose investigational product Other criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Ambulatory blood pressure</keyword>
	<keyword>Type 2 diabetes</keyword>
</DOC>